Search results for "Celltrion"

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully transferred a novel antibody technology...
Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima (active ingredient:...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market

Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market

Celltrion announced on the 12th its acquisition of Gifrer, a French healthcare specialist with a 114-year history.
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour...
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States,...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation

Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation

Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”

Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”

Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?

Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?

The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.